Lobbying Filing Details

Activity 1

Bankruptcy

HR 5488, S 2805, "Protecting Our Courts from Foreign Manipulation Act of 2023", regarding provisions relating to transparency from foreign investors in US litigation. Issues related to: - Chapter 11 corporate bankruptcy process - Litigation reform

Lobbyists (5)

• MRS. JANE MARGARET ADAMS
• KELLY WATERS
• LARRY CAMM
• RILEY SWINEHART
• ABIGAIL PINKELE

Government Entities (2)

• SENATE
• HOUSE OF REPRESENTATIVES

Activity 2

Budget/Appropriations

Issues related to: - Contact lens safety, peripheral artery disease, and stroke care, specifically to provisions regarding appropriations report language - Appropriations for Labor Health and Human Services - NIH funding

Lobbyists (6)

• MRS. JANE MARGARET ADAMS
• LEIF BRIERLEY
• LARRY CAMM
• DEANA MCRAE
• TIMOTHY SWOPE
• COLLEEN VIVALDI

Government Entities (2)

• SENATE
• HOUSE OF REPRESENTATIVES

Activity 3

Consumer Issues/Safety/Products

Issues related to: - Counterfeit healthcare goods - Brand protection

Lobbyists (1)

• LEIF BRIERLEY

Government Entities (2)

• SENATE
• HOUSE OF REPRESENTATIVES

Activity 4

Copyright/Patent/Trademark

- S 150, "Affordable Prescriptions for Patients Act of 2023", regarding all provisions. - S 79/HR 1717, "Interagency Patent Coordination and Improvement Act of 2023", regarding all provisions. - Issues related to intellectual property.

Lobbyists (3)

• MRS. JANE MARGARET ADAMS
• DAVID KAVANAUGH
• TIMOTHY SWOPE

Government Entities (2)

• SENATE
• HOUSE OF REPRESENTATIVES

Activity 5

Environment/Superfund

Issues related to - Clean energy - Environmental sustainability Final Rule - U.S. EPA Rulemaking on National Emission Standards for Hazardous Air Pollutants (NESHAP) for Ethylene Oxide.

Lobbyists (2)

• KELLY WATERS
• RILEY SWINEHART

Government Entities (2)

• SENATE
• HOUSE OF REPRESENTATIVES

Activity 6

Health Issues

- S 1375/HR 830, "HELP Copays Act", regarding all provisions. - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation. - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions. - S 1355/HR 2940, "PASTEUR Act", regarding all provisions. - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions. - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions. - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions. - S 3131/HR 5539, "ORPHAN Cures Act", regarding all provisions. - HR 5372, "Expanding Access to Seniors Access to Lower Cost Medicines Act of 2023", regarding all provisions. - S 2305, "The Biosimilar Red Tape Elimination Act", regarding all provisions. - HR 1352, "Increasing Access to Biosimilars Act of 2023", regarding all provisions. Issues related to: - Obesity - Biosimilars - Health equity and diversity in clinical trials - Myopia - Ambulatory surgical services - Access to sterilization capacity for medical technologies - Peripheral artery disease - Cardiovascular health - Stroke care - FDA medical device shortage reporting requirements - Alternative funding programs - 340B - PBM practices - Health care workforce wellbeing - Medicaid Drug Rebate Program

Lobbyists (14)

• MRS. JANE MARGARET ADAMS
• DAVID KAVANAUGH
• KELLY WATERS
• LEIF BRIERLEY
• LARRY CAMM
• RILEY SWINEHART
• ABIGAIL PINKELE
• DEANA MCRAE
• AMY PELLEGRINO
• WENDY SUSSMAN
• MRS. MEGHAN DRENAN STONE
• TIMOTHY SWOPE
• COLLEEN VIVALDI
• EMELY SANCHEZ

Government Entities (3)

• SENATE
• HOUSE OF REPRESENTATIVES
• Centers For Medicare and Medicaid Services (CMS)

Activity 7

Labor Issues/Antitrust/Workplace

- Issues related to diversity, equity and inclusion.

Lobbyists (1)

• LARRY CAMM

Government Entities (2)

• HOUSE OF REPRESENTATIVES
• Federal Trade Commission (FTC)

Activity 8

Medicare/Medicaid

Issues related to the Medicaid Drug Rebate Program.

Lobbyists (2)

• AMY PELLEGRINO
• WENDY SUSSMAN

Government Entities (5)

• SENATE
• HOUSE OF REPRESENTATIVES
• Office of Management & Budget (OMB)
• Health & Human Services, Dept of (HHS)
• Centers For Medicare and Medicaid Services (CMS)

Activity 9

Pharmacy

- HR 4490, "To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the to the ultimate user, and for other purposes", regarding all provisions. - Issues related to drug shortages.

Lobbyists (5)

• ABIGAIL PINKELE
• AMY PELLEGRINO
• WENDY SUSSMAN
• MRS. MEGHAN DRENAN STONE
• TIMOTHY SWOPE

Government Entities (2)

• SENATE
• HOUSE OF REPRESENTATIVES

Activity 10

Science/Technology

S 3312, "Artificial Intelligence Research, Innovation, and Accountability Act", regarding all provisions. Issues related to: - Data privacy - Cybersecurity - Artificial intelligence

Lobbyists (1)

• LEIF BRIERLEY

Government Entities (2)

• SENATE
• HOUSE OF REPRESENTATIVES

Activity 11

Taxation/Internal Revenue Code

S 866/HR 2673, "American Innovation and R&D Competitiveness Act of 2023", regarding provisions related to research & development expensing. Issues related to: - OECD proposals on global tax & implementation - R&D expensing - Corporate tax provisions in TCJA - Corporate Alternative Minimum Tax implementation

Lobbyists (4)

• MRS. JANE MARGARET ADAMS
• DAVID KAVANAUGH
• KELLY WATERS
• RILEY SWINEHART

Government Entities (2)

• HOUSE OF REPRESENTATIVES
• Treasury, Dept of

Activity 12

Trade (domestic/foreign)

Issues related to: - Medical supply chains - TRIPS Waiver

Lobbyists (5)

• MRS. JANE MARGARET ADAMS
• DAVID KAVANAUGH
• RILEY SWINEHART
• WENDY SUSSMAN
• TIMOTHY SWOPE

Government Entities (2)

• SENATE
• HOUSE OF REPRESENTATIVES